{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:29:09Z","timestamp":1790342949541,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jpain.2024.104603","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T20:35:56Z","timestamp":1718310956000},"page":"104603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Unmet Need: Mechanistic and Translational Studies of Sickle Cell Disease Pain as a Whole-Person Health Challenge"],"prefix":"10.1016","volume":"25","author":[{"given":"Inna","family":"Belfer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmeline","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene M.","family":"Langevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpain.2024.104603_bib1","series-title":"StatPearls","first-page":"1","article-title":"Sickle cell disease","author":"Sedrak","year":"2023"},{"key":"10.1016\/j.jpain.2024.104603_bib2","unstructured":"American Society of Hematology. Sickle cell disease. Accessed March 29, 2024. https:\/\/www.hematology.org\/education\/patients\/anemia\/sickle-cell-disease."},{"issue":"8","key":"10.1016\/j.jpain.2024.104603_bib3","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/01612840.2018.1443530","article-title":"Stigma of sickle cell disease: a systematic review","volume":"39","author":"Bulgin","year":"2018","journal-title":"Issues Ment Health Nurs"},{"issue":"8","key":"10.1016\/j.jpain.2024.104603_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.NAJ.0000947472.45064.d5","article-title":"Improving sickle cell disease care","volume":"123","author":"Jackson","year":"2023","journal-title":"Am J Nurs"},{"key":"10.1016\/j.jpain.2024.104603_bib5","unstructured":"National Academies of Sciences, Engineering, and Medicine. Addressing sickle cell disease: a strategic plan and blueprint for action. Published September 10, 2020. Accessed March 29, 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK566471\/."},{"key":"10.1016\/j.jpain.2024.104603_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.728693","article-title":"Extracellular vesicles in sickle cell disease: plasma concentration, blood cell types origin distribution and biological properties","volume":"8","author":"Nader","year":"2021","journal-title":"Front Med"},{"issue":"7","key":"10.1016\/j.jpain.2024.104603_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214355","article-title":"Sickle cell disease complications: prevalence and resource utilization","volume":"14","author":"Shah","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jpain.2024.104603_bib8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/MOH.0000000000000491","article-title":"Pain and sickle cell disease","volume":"26","author":"Aich","year":"2019","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jpain.2024.104603_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134445","article-title":"Neuropathic pain in individuals with sickle cell disease","volume":"714","author":"Sharma","year":"2020","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jpain.2024.104603_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2020.102327","article-title":"Review\/overview of pain in sickle cell disease","volume":"49","author":"Ballas","year":"2020","journal-title":"Complement Ther Med"},{"issue":"2","key":"10.1016\/j.jpain.2024.104603_bib11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/2049463720920682","article-title":"Mechanisms of pain in sickle cell disease","volume":"15","author":"Takaoka","year":"2021","journal-title":"Br J Pain"},{"issue":"8","key":"10.1016\/j.jpain.2024.104603_bib12","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/pm\/pnaa464","article-title":"Pain experiences of adults with sickle cell disease and hematopoietic stem cell transplantation: a qualitative study","volume":"22","author":"Al Hamayel","year":"2021","journal-title":"Pain Med"},{"issue":"4","key":"10.1016\/j.jpain.2024.104603_bib13","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/bjh.15169","article-title":"Pain and opioid use after reversal of sickle cell disease following HLA-matched sibling haematopoietic stem cell transplant","volume":"184","author":"Darbari","year":"2019","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.jpain.2024.104603_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1590\/0034-7167-2016-0409","article-title":"Quality of life in adults with sickle cell disease: an integrative review of the literature","volume":"71","author":"de Freitas","year":"2018","journal-title":"Rev Bras Enferm"},{"issue":"1","key":"10.1016\/j.jpain.2024.104603_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/bloodadvances.2019000128","article-title":"Assessment of health-related quality of life among adults hospitalized with sickle cell disease vaso-occlusive crisis","volume":"4","author":"Esham","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jpain.2024.104603_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2122056","article-title":"Health-related quality of life and adherence to hydroxyurea and other disease-modifying therapies among individuals with sickle cell disease: a systematic review","volume":"2022","author":"Yang","year":"2022","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jpain.2024.104603_bib17","unstructured":"National Institutes of Health, Approaches to effective therapeutic management of pain for people with sickle cell disease (SCD). Published July 30, 2021. Accessed March 29, 2024. https:\/\/www.nccih.nih.gov\/news\/events\/approaches-to-effective-therapeutic-management-of-pain-for-people-with-sickle-cell-disease."},{"key":"10.1016\/j.jpain.2024.104603_bib18","unstructured":"National Heart Lung and Blood Institute. Evidence-based management of sickle cell disease. expert panel report. Published September 2014. Accessed March 29, 2024. https:\/\/www.nhlbi.nih.gov\/health-topics\/evidence-based-management-sickle-cell-disease."},{"issue":"1 Suppl 1","key":"10.1016\/j.jpain.2024.104603_bib19","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.amepre.2016.02.012","article-title":"Chronic opioid therapy and central sensitization in sickle cell disease","volume":"51","author":"Carroll","year":"2016","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jpain.2024.104603_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.trsl.2021.03.007","article-title":"Pain in sickle cell disease: current and potential translational therapies","volume":"234","author":"Sagi","year":"2021","journal-title":"Transl Res"},{"key":"10.1016\/j.jpain.2024.104603_bib21","series-title":"GeneReviews\u00ae [Internet]","first-page":"1993","article-title":"Sickle cell disease","author":"Bender","year":"2003"},{"issue":"38","key":"10.1016\/j.jpain.2024.104603_bib22","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000035237","article-title":"Understanding sickle cell disease: causes, symptoms, and treatment options","volume":"102","author":"Elendu","year":"2023","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/j.jpain.2024.104603_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11916-020-00854-y","article-title":"A comprehensive review of the treatment and management of pain in sickle cell disease","volume":"24","author":"Fiocchi","year":"2020","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.jpain.2024.104603_bib24","unstructured":"U.S. Food and Drug Administration. FDA approves first gene therapies to treat patients with sickle cell disease. Published December 8, 2023. Accessed March 9, 2024. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-gene-therapies-treat-patients-sickle-cell-disease."},{"issue":"11","key":"10.1016\/j.jpain.2024.104603_bib25","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S2352-4642(23)00201-8","article-title":"The evolving treatment landscape for children with sickle cell disease","volume":"7","author":"Jacob","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"issue":"1","key":"10.1016\/j.jpain.2024.104603_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13045-022-01237-z","article-title":"Advances in the diagnosis and treatment of sickle cell disease","volume":"15","author":"Brandow","year":"2022","journal-title":"J Hematol Oncol"},{"issue":"8","key":"10.1016\/j.jpain.2024.104603_bib27","article-title":"Advancements in sickle cell disease (SCD) treatment: a review of novel pharmacotherapies and their impact on patient outcomes","volume":"15","author":"Khan","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jpain.2024.104603_bib28","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/bloodadvances.2020001851","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain","author":"Brandow","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jpain.2024.104603_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fpain.2023.1279361","article-title":"Precision, integrative medicine for pain management in sickle cell disease","volume":"4","author":"Smith","year":"2023","journal-title":"Front Pain Res"},{"issue":"4","key":"10.1016\/j.jpain.2024.104603_bib30","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ajh.26871","article-title":"Intranasal fentanyl works\u2014Why are we not using it more to treat acute pain in sickle cell disease?","volume":"98","author":"Oni","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jpain.2024.104603_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134534","article-title":"Opioid treatment for acute and chronic pain in patients with sickle cell disease","volume":"714","author":"Carroll","year":"2020","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1016\/j.jpain.2024.104603_bib32","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/neurolint13030038","article-title":"Selective serotonin reuptake inhibitors and adverse effects: a narrative review","volume":"13","author":"Edinoff","year":"2021","journal-title":"Neurol Int"},{"issue":"5","key":"10.1016\/j.jpain.2024.104603_bib33","article-title":"Vitamin D supplementation for sickle cell disease","volume":"5","author":"Soe","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.jpain.2024.104603_bib34","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/j.pain.0000000000003009","article-title":"A cognitive-behavioral digital health intervention for sickle cell disease pain in adolescents: a randomized, controlled, multicenter trial","volume":"165","author":"Palermo","year":"2024","journal-title":"Pain"},{"issue":"9 Suppl","key":"10.1016\/j.jpain.2024.104603_bib35","first-page":"S256","article-title":"Differential diagnosis: nociceptive and neuropathic pain","volume":"12","author":"Nicholson","year":"2006","journal-title":"Am\u00a0J\u00a0Manag\u00a0Care"},{"issue":"3","key":"10.1016\/j.jpain.2024.104603_bib36","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/ejh.13430","article-title":"The vaso-occlusive pain crisis in sickle cell disease: definition, pathophysiology, and management","volume":"105","author":"Darbari","year":"2020","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.jpain.2024.104603_bib37","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/s13023-021-02096-6","article-title":"A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease","volume":"16","author":"Zaidi","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10.1016\/j.jpain.2024.104603_bib38","article-title":"Emerging therapies for the management of pain and vaso-occlusive crises in patients with sickle cell disease: a systematic review of randomized controlled trials","volume":"15","author":"Lowe","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.jpain.2024.104603_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2022.10233","article-title":"Sickle cell disease: a review","volume":"328","author":"Kavanagh","year":"2022","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1016\/j.jpain.2024.104603_bib40","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1097\/j.pain.0000000000000824","article-title":"Sickle cell disease: a natural model of acute and chronic pain","volume":"158","author":"Brandow","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2024.104603_bib41","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.hoc.2022.06.009","article-title":"Chronic pain: prevalence and management","volume":"36","author":"Carroll","year":"2022","journal-title":"Hematol Oncol Clin N Am"},{"issue":"3","key":"10.1016\/j.jpain.2024.104603_bib42","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1526-4637.2009.00601.x","article-title":"Pain syndromes in sickle cell disease: an update","volume":"10","author":"Niscola","year":"2009","journal-title":"Pain Med"},{"key":"10.1016\/j.jpain.2024.104603_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"10.1016\/j.jpain.2024.104603_bib44","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ajh.26063","article-title":"Impact of sickle cell disease on patients\u2019 daily lives, symptoms reported, and disease management strategies: results from the international Sickle Cell World Assessment Survey (SWAY)","volume":"96","author":"Osunkwo","year":"2021","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.jpain.2024.104603_bib45","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/JMU.JMU_47_20","article-title":"Sonographic assessment of some abdominal organs in children with sickle cell disease in Ilorin, Nigeria","volume":"29","author":"Muftaudeen","year":"2020","journal-title":"J Med Ultrasound"},{"issue":"5","key":"10.1016\/j.jpain.2024.104603_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2022.103533","article-title":"Acute and chronic pain management in patients with sickle cell disease in the modern era: a comprehensive review","volume":"61","author":"Tolu","year":"2022","journal-title":"Transfus Apher Sci"},{"issue":"10","key":"10.1016\/j.jpain.2024.104603_bib47","article-title":"Musculoskeletal manifestations of sickle cell disease: a review","volume":"7","author":"Vaishya","year":"2015","journal-title":"Cureus"},{"key":"10.1016\/j.jpain.2024.104603_bib48","article-title":"Myonecrosis in a sickle cell-diseased patient: a case report and literature review","volume":"2020","author":"Almomen","year":"2020","journal-title":"Case Rep Orthop"},{"issue":"8","key":"10.1016\/j.jpain.2024.104603_bib49","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1089\/acm.2021.0255","article-title":"Moving the complementary and integrative health research field toward whole person health","volume":"27","author":"Langevin","year":"2021","journal-title":"J Altern Complement Med"},{"issue":"5","key":"10.1016\/j.jpain.2024.104603_bib50","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.4410","article-title":"Management of chronic pain in adults living with sickle cell disease in the era of the opioid epidemic: a qualitative study","volume":"2","author":"Sinha","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.jpain.2024.104603_bib51","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/pm\/pnw046","article-title":"Characterization of chronic pain and opioid usage in adult sickle cell disease patients referred to a comprehensive pain clinic","volume":"17","author":"Zoheiry","year":"2016","journal-title":"Pain Med"},{"issue":"5","key":"10.1016\/j.jpain.2024.104603_bib52","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.14070","article-title":"Examining mental health, education, employment, and pain in sickle cell disease","volume":"6","author":"Harris","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.jpain.2024.104603_bib53","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/AJP.0000000000000957","article-title":"Severe pain profiles and associated sociodemographic and clinical characteristics in individuals with sickle cell disease","volume":"37","author":"Knisely","year":"2021","journal-title":"Clin J Pain"},{"issue":"4","key":"10.1016\/j.jpain.2024.104603_bib54","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/19371918.2019.1606754","article-title":"An integrative review of the prevalence of depression among pediatric patients with sickle cell disease","volume":"34","author":"Moody","year":"2019","journal-title":"Soc Work Public Health"},{"issue":"6","key":"10.1016\/j.jpain.2024.104603_bib55","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/AJP.0000000000000827","article-title":"Changes in pain and psychosocial functioning and transition to chronic pain in pediatric sickle cell disease: a cohort follow-up study","volume":"36","author":"Sil","year":"2020","journal-title":"Clin J Pain"},{"issue":"2","key":"10.1016\/j.jpain.2024.104603_bib56","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10880-021-09837-6","article-title":"Biopsychosocial factors associated with parenting stress in pediatric sickle cell disease","volume":"29","author":"Johnson","year":"2022","journal-title":"J Clin Psychol Med Settings"},{"issue":"3","key":"10.1016\/j.jpain.2024.104603_bib57","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.1737","article-title":"Comparison of US federal and foundation funding of research for sickle cell disease and cystic fibrosis and factors associated with research productivity","volume":"3","author":"Farooq","year":"2020","journal-title":"JAMA Network Open"},{"issue":"4","key":"10.1016\/j.jpain.2024.104603_bib58","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/NCM.0000000000000260","article-title":"Barriers to care for persons with sickle cell disease: the case manager's opportunity to improve patient outcomes","volume":"23","author":"Brennan-Cook","year":"2018","journal-title":"Prof Case Manag"},{"issue":"1","key":"10.1016\/j.jpain.2024.104603_bib59","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1182\/asheducation-2017.1.412","article-title":"Improving emergency department-based care of sickle cell pain","volume":"2017","author":"Glassberg","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"2","key":"10.1016\/j.jpain.2024.104603_bib60","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.pmn.2014.05.015","article-title":"Sickle cell disease pain management in adolescents: a literature review","volume":"16","author":"Wilson","year":"2015","journal-title":"Pain Manag Nurs"},{"key":"10.1016\/j.jpain.2024.104603_bib61","unstructured":"Hurt A.The complexity of sickle cell pain: an overview. Published June 18, 2020. Accessed March 29, 2024. https:\/\/www.medcentral.com\/pain\/complexity-sickle-cell-pain-overview."},{"issue":"8","key":"10.1016\/j.jpain.2024.104603_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255956","article-title":"The gut microbiome in sickle cell disease: characterization and potential implications","volume":"16","author":"Brim","year":"2021","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.jpain.2024.104603_bib63","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1182\/blood-2013-04-498105","article-title":"Mast cell activation contributes to sickle cell pathobiology and pain in mice","volume":"122","author":"Vincent","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jpain.2024.104603_bib64","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/1535370214544275","article-title":"Sickle cell disease in mice is associated with sensitization of sensory nerve fibers","volume":"240","author":"Kenyon","year":"2015","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.jpain.2024.104603_bib65","article-title":"Electroacupuncture in conscious free-moving mice reduces pain by ameliorating peripheral and central nociceptive mechanisms","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"issue":"18","key":"10.1016\/j.jpain.2024.104603_bib66","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1182\/blood-2012-04-383430","article-title":"Sickle cell pain: a critical reappraisal","volume":"120","author":"Ballas","year":"2012","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jpain.2024.104603_bib67","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000584","article-title":"Research in sickle cell disease: from bedside to bench to bedside","volume":"5","author":"Salinas Cisneros","year":"2021","journal-title":"Hemasphere"},{"issue":"10","key":"10.1016\/j.jpain.2024.104603_bib68","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2021.3467","article-title":"Improving outcomes for patients with sickle cell disease in the United States. Making the case for more resources, surveillance, and longitudinal data","volume":"2","author":"Kanter","year":"2021","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.jpain.2024.104603_bib69","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.hoc.2022.08.008","article-title":"Structural racism and impact on sickle cell disease. Sickle cell lives matter","volume":"36","author":"Smith","year":"2022","journal-title":"Hematol Oncol Clin North Am"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590024005443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590024005443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T20:44:49Z","timestamp":1759351489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590024005443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":69,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1526590024005443"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2024.104603","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unmet Need: Mechanistic and Translational Studies of Sickle Cell Disease Pain as a Whole-Person Health Challenge","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2024.104603","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Published by Elsevier Inc. on behalf of United States Association for the Study of Pain, Inc","name":"copyright","label":"Copyright"}],"article-number":"104603"}}